TASIGNA 200 MG CAPSULE

nilotinib
$94.1452per EA

Strength

200 mg/1

NDC

00078052687

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/1/2016

Approval Type

New Drug (NDA)

FDA Application

NDA022068

On Market Since

10/29/2007

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C8 Inducers
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 2D6 Inhibitors
Kinase Inhibitor
P-Glycoprotein Inhibitors
UGT1A1 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+9.0%